Products for Research Use Only
RegisterLogin

LDN212854

CAT: 0013-GTR19163232-01Size: 200 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19163232-01Size:200 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
LDN-212854 is a novel BMP inhibitor that exhibits substantially greater selectivity for BMP versus the TGF-β type I receptors; possesses a bias towards ALK2 (IC50=1.3 nM) versus ALK1 and ALK3 compared to other inhibitors.
CAS Number
1432597-26-6
Product Name Alternative
LDN212854 | LDN 212854 | LDN-212854
Purity
>98% (HPLC)
Solubility
DMSO: 81 mg/mL warmed (199.27 mM)
Smiles
C12=C (C3=C4N=CC (C5=CC=C (N6CCNCC6) C=C5) =CN4N=C3) C=CC=C1N=CC=C2
Molecular Formula
C25H22N6
Molecular Weight
406.48
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
5- (6- (4- (piperazin-1-yl) phenyl) pyrazolo[1,5-a]pyrimidin-3-yl) quinoline

Alternative Products

CatalogName
MBS576671LDN212854
217225BMP Inhibitor III, LDN-212854 (Abl Inhibitor V, LDN212854, Bone Morphogenetic Protein Inhibitor III, PDGFR Tyrosine Kinase Inhibitor XXIV, RIP2 Inhibitor I, RIPK2 Inhibitor I, 5- (6- (4- (Piperazin-1-yl) phenyl) pyrazolo[1,5-a]pyrimidin-3-yl) quinoline)

Popular Products